NextCure Inc. (NXTC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NextCure Inc.

    NASDAQ: NXTC · Real-Time Price · USD
    4.95
    0.01 (0.20%)
    At close: Sep 08, 2025, 10:17 AM

    NextCure Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.87M 3.68M 4.48M 4.3M
    Gross Profit
    		 -2.87M -3.68M -4.48M -4.3M
    Operating Income
    		 -59.75M -67.64M -75.91M -70.77M
    Interest Income
    		 n/a n/a 1.17M 1.32K
    Pretax Income
    		 -55.65M -62.72M -74.73M -69.39M
    Net Income
    		 -55.65M -62.72M -69.43M -69.39M
    Selling & General & Admin
    		 15.72M 19.71M 21.71M 20.57M
    Research & Development
    		 41.49M 47.93M 54.2M 50.19M
    Other Expenses
    		 2.54M n/a n/a n/a
    Operating Expenses
    		 59.75M 67.64M 75.91M 70.77M
    Interest Expense
    		 n/a n/a n/a 77K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 59.75M 67.64M 75.91M 70.77M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 2.33M 2.32M 2.31M 2.3M
    Shares Outstanding (Diluted)
    		 2.33M 2.32M 2.31M 2.3M
    EPS (Basic)
    		 -23.88 -27.04 -32.32 -30.15
    EPS (Diluted)
    		 -23.88 -27.04 -32.32 -30.15
    EBITDA
    		 -54.34M -59.04M -70.25M -65.01M
    EBIT
    		 -57.21M -62.72M -74.73M -69.31M
    Depreciation & Amortization
    		 2.87M 3.68M 4.48M 4.3M

    Add to Watchlist